News >

Delivering Deep, Durable Remissions Remains Primary Focus in Multiple Myeloma

Caroline Seymour
Published: Monday, Jan 20, 2020

Thomas G. Martin, MD, a clinical professor of medicine in the Adult Leukemia and Bone Marrow Transplantation Program at the University of California, San Francisco, Seattle Cancer Care Alliance

Thomas G. Martin, MD

With the number of effective combinations and novel agents that have surfaced in recent years, patients with multiple myeloma should be treated as aggressively as possible, whether in the frontline setting or early relapse setting, to provide lasting remission durations, explained Thomas G. Martin, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication